跳至主要内容
临床试验/IRCT20230608058428N1
IRCT20230608058428N1尚未招募3 期

The effect of Elaeagnus angustifolia fruit extract capsule on childbirth after-pains among multiparous women

Mashhad University of Medical Sciences0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 35 years(—)
性别
Female

入选标准

  • have the desire to enter the study.
  • age between 18 to 35 years old.
  • At least be literate in reading and writing.
  • The current birth be the second to fourth birth.
  • Normal delivery, singleton and full term. (Based on the ultrasound of the first trimester or last menstrual valid period)
  • The baby be alive and healthy.
  • If there are pains with a score of 4 to 10 based on the pain ruler.
  • Cephalic presentation.
  • The baby's weight should be 2500-4000 grams. (weighing recorded in the baby's file)
  • Not to have any past medical and mental history. (heart disease, chronic Hypertension, and pre-eclampsia, diabetes, kidney and lung disease, autoimmune diseases and all types of neurological and mental diseases)
  • Not to be allergic to Elaeagnus angustifolia. (Symptoms of allergy include: rhinitis, rhinoconjunctivitis, dermatitis)
  • Not to be addicted to drugs, psychotropic substances, alcohol or tobacco.
  • Not to have severe post partum bleeding after delivery.(Bleeding that requires medical measures (other than receiving centocinone) or requiring blood transfer and moving to operating room.)
  • Not having any history of uterine surgery or caesarean section
  • Drug analgesia has not been used to reduce labor pain.(Spinal, Epidural, Entonox gas)
  • Not to have 3 and 4 perineum tears.
  • The first, second, and third stages of labor should be normal.(First stage: no fast or slow progressing labor, no prolonged rupture of membranes (more than 12 hours), second stage: no instrumental labor, no third and fourth degree rupture, third stage: spontaneous exit of the placenta and membranes)

排除标准

  • Not intend to continue the research
  • Mother's refusal to take more than one capsule of Elaeagnus angustifolia or placebo
  • The impossibility of continuing to breastfeed the baby (Due to the death of the baby, hospitalization in NICU)
  • Any problem that disturbs the routine care of the mother.(Transferring the mother to the operating room-early discharge before 24 hours-hemorrhage or any obstetric problems of the mother that require treatment.)

研究者

相似试验